Richard D. Pilnik - Net Worth and Insider Trading
Richard D. Pilnik Net Worth
The estimated net worth of Richard D. Pilnik is at least $707,498 dollars as of 2024-05-24. Richard D. Pilnik is the Director of DiaMedica Therapeutics Inc and owns about 248,245 shares of DiaMedica Therapeutics Inc (DMAC) stock worth over $707,498. Details can be seen in Richard D. Pilnik's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard D. Pilnik has not made any transactions after 2023-06-23 and currently still holds the listed stock(s).
Transaction Summary of Richard D. Pilnik
Richard D. Pilnik Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard D. Pilnik owns 1 companies in total, including DiaMedica Therapeutics Inc (DMAC) .
Click here to see the complete history of Richard D. Pilnik’s form 4 insider trades.
Insider Ownership Summary of Richard D. Pilnik
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc | 2023-06-23 | director |
Richard D. Pilnik Latest Holdings Summary
Richard D. Pilnik currently owns a total of 1 stock. Richard D. Pilnik owns 248,245 shares of DiaMedica Therapeutics Inc (DMAC) as of June 23, 2023, with a value of $707,498.
Latest Holdings of Richard D. Pilnik
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc | 2023-06-23 | 248,245 | 2.85 | 707,498 |
Holding Weightings of Richard D. Pilnik
Richard D. Pilnik Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard D. Pilnik has made a total of 6 transactions in DiaMedica Therapeutics Inc (DMAC) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in DiaMedica Therapeutics Inc is the acquisition of 38,363 shares on June 23, 2023, which cost Richard D. Pilnik around $149,999.
Insider Trading History of Richard D. Pilnik
- 1
Richard D. Pilnik Trading Performance
GuruFocus tracks the stock performance after each of Richard D. Pilnik's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard D. Pilnik is 16.43%. GuruFocus also compares Richard D. Pilnik's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard D. Pilnik within 3 months outperforms 5 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard D. Pilnik's insider trading performs compared to the benchmark.
Performance of Richard D. Pilnik
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 25.41 | | | | | |
| Relative Return to S&P 500(%) | 24.05 | | | | | |
Richard D. Pilnik Ownership Network
Richard D. Pilnik Owned Company Details
What does DiaMedica Therapeutics Inc do?
Who are the key executives at DiaMedica Therapeutics Inc?
Richard D. Pilnik is the director of DiaMedica Therapeutics Inc. Other key executives at DiaMedica Therapeutics Inc include CFO and Secretary Scott Kellen , 10 percent owner Jan Stahlberg , and 10 percent owner Ab Trill .
DiaMedica Therapeutics Inc (DMAC) Insider Trades Summary
Over the past 18 months, Richard D. Pilnik made 2 insider transaction in DiaMedica Therapeutics Inc (DMAC) with a net purchase of 73,363. Other recent insider transactions involving DiaMedica Therapeutics Inc (DMAC) include a net purchase of 215,000 shares made by Randall Michael Giuffre , a net purchase of 1,470,588 shares made by Koch Thomas Von , and a net purchase of 527,114 shares made by David J. Wambeke .
In summary, during the past 3 months, insiders sold 0 shares of DiaMedica Therapeutics Inc (DMAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,855,847 shares of DiaMedica Therapeutics Inc (DMAC) were sold and 5,177,486 shares were bought by its insiders, resulting in a net purchase of 2,321,639 shares.
DiaMedica Therapeutics Inc (DMAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
DiaMedica Therapeutics Inc Insider Transactions
Richard D. Pilnik Mailing Address
Above is the net worth, insider trading, and ownership report for Richard D. Pilnik. You might contact Richard D. Pilnik via mailing address: 2 Carlson Parkway, Suite 260, Minneapolis Mn 55447.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
